Skip to content
TriangleGet started
A clearer view of the evidence.
Cancer evidence / Population explorer

Chronic myeloproliferative disorders (CMD)

All Ages · Both Sexes · All Stages

5-year relative survival

86.8%for this source population

95% confidence interval 86.5%–87.1%

All Ages · Both Sexes · All Stages
Relative survivalYears after diagnosis
Relative survival after diagnosis0%25%50%75%100%0135710
Selected population 5-year: 86.8%

Shading: selected population’s 95% confidence interval. Lines connect published annual estimates.

SEER · 2000-2022 diagnoses
i

A population estimate, not a personal forecast.

Source population: Chronic myeloproliferative disorders (CMD)Captured September 2026 · Research preview